Social bias in artificial intelligence algorithms designed to improve cardiovascular risk assessment relative to the Framingham Risk Score: a protocol for a systematic review

被引:0
|
作者
Garcha, Ivneet [1 ]
Phillips, Susan Paula [2 ]
机构
[1] Queens Univ, Med, Kingston, ON, Canada
[2] Queens Univ, Dept Family Med, Kingston, ON, Canada
来源
BMJ OPEN | 2023年 / 13卷 / 05期
关键词
primary care; preventive medicine; social medicine; cardiology;
D O I
10.1136/bmjopen-2022-067638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCardiovascular disease (CVD) prevention relies on timely identification of and intervention for individuals at risk. Risk assessment models such as the Framingham Risk Score (FRS) have been shown to over-estimate or under-estimate risk in certain groups, such as socioeconomically disadvantaged populations. Artificial intelligence (AI) and machine learning (ML) could be used to address such equity gaps to improve risk assessment; however, critical appraisal is warranted before ML-informed clinical decision-making is implemented.Methods and analysisThis study will employ an equity-lens to identify sources of bias (ie, race/ethnicity, gender and social stratum) in ML algorithms designed to improve CVD risk assessment relative to the FRS. A comprehensive literature search will be completed using MEDLINE, Embase and IEEE to answer the research question: do AI algorithms that are designed for the estimation of CVD risk and that compare performance with the FRS address the sources of bias inherent in the FRS? No study date filters will be imposed on the search, but English language filters will be applied. Studies describing a specific algorithm or ML approach that provided a risk assessment output for coronary artery disease, heart failure, cardiac arrhythmias (ie, atrial fibrillation), stroke or a global CVD risk score, and that compared performance with the FRS are eligible for inclusion. Papers describing algorithms for the diagnosis rather than the prevention of CVD will be excluded. A structured narrative review analysis of included studies will be completed.Ethics and disseminationEthics approval was not required. Ethics exemption was formally received from the General Research Ethics Board at Queen's University. The completed systematic review will be submitted to a peer-reviewed journal and parts of the work will be presented at relevant conferences.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] A Systematic Review of Artificial Intelligence Models for Time-to-Event Outcome Applied in Cardiovascular Disease Risk Prediction
    Teshale, Achamyeleh Birhanu
    Htun, Htet Lin
    Vered, Mor
    Owen, Alice J.
    Freak-Poli, Rosanne
    JOURNAL OF MEDICAL SYSTEMS, 2024, 48 (01)
  • [42] Artificial intelligence in the risk prediction models of cardiovascular disease and development of an independent validation screening tool: a systematic review
    Yue Cai
    Yu-Qing Cai
    Li-Ying Tang
    Yi-Han Wang
    Mengchun Gong
    Tian-Ci Jing
    Hui-Jun Li
    Jesse Li-Ling
    Wei Hu
    Zhihua Yin
    Da-Xin Gong
    Guang-Wei Zhang
    BMC Medicine, 22
  • [43] Assessment of Endothelial Function by Peripheral Arterial Tonometry Predicts Cardiovascular Events Beyond the Framingham Risk Score
    Rubinshtein, Ronen
    Kuvin, Jeffrey T.
    Soffler, Morgan
    Lennon, Ryan J.
    Nelson, Rebecca E.
    Pumper, Geralyn M.
    Lerman, Lilach O.
    Lerman, Amir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A457 - A457
  • [44] Cardiovascular risk assessment according to the Framingham score and abdominal obesity in individuals seen by a clinical school of nutrition
    Menezes de Oliveira, Alane Cabral
    Ferreira, Raphaela Costa
    Santos, Arianne Albuquerque
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (02): : 138 - 144
  • [45] Potentiality of algorithms and artificial intelligence adoption to improve medication management in primary care: a systematic review
    Damiani, Gianfranco
    Altamura, Gerardo
    Zedda, Massimo
    Nurchis, Mario Cesare
    Aulino, Giovanni
    Alizadeh, Aurora Heidar
    Cazzato, Francesca
    Della Morte, Gabriele
    Caputo, Matteo
    Grassi, Simone
    Oliva, Antonio
    BMJ OPEN, 2023, 13 (03):
  • [46] General practitioner and pharmacist collaboration: does this improve risk factors for cardiovascular disease and diabetes? A systematic review protocol
    Chaudhri, Kanika
    Hayek, Adina
    Liu, Hueiming
    Joshi, Rohina
    BMJ OPEN, 2019, 9 (08):
  • [47] MOBILE HEALTH APPS FOR CARDIOVASCULAR RISK ASSESSMENT: A SYSTEMATIC REVIEW
    Chavez Ecos, Fabian
    Chavez, Rodrigo
    Vergara Sanchez, Carlos A.
    Chavez, Miguel
    Camacho Caballero, Kiara
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2596 - 2596
  • [48] Cardiovascular risk assessment scores for people with diabetes: a systematic review
    P. Chamnan
    R. K. Simmons
    S. J. Sharp
    S. J. Griffin
    N. J. Wareham
    Diabetologia, 2009, 52
  • [49] Cardiovascular risk assessment scores for people with diabetes: a systematic review
    Chamnan, P.
    Simmons, R. K.
    Sharp, S. J.
    Griffin, S. J.
    Wareham, N. J.
    DIABETOLOGIA, 2009, 52 (10) : 2001 - 2014
  • [50] Mobile health apps for cardiovascular risk assessment: a systematic review
    Chavez-Ecos, Fabian A.
    Chavez-Ecos, Rodrigo
    Sanchez, Carlos Vergara
    Chavez-Gutarra, Miguel A.
    Agarwala, Anandita
    Camacho-Caballero, Kiara
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11